United Therapeutics holds the cleaner structural position, with the lead spread across growth and stability. Novo Nordisk A/S still has the edge on profitability, which keeps the comparison from looking entirely one-sided. On the market side, United Therapeutics is in better shape — its trend is intact while Novo Nordisk A/S's trend has broken down. That puts structure and market broadly in agreement — United Therapeutics's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels.
The clearest separation starts in growth, but stability adds another real layer to the result. United Therapeutics Corporation leads by 8 points on the overall comparison score.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.
The clearest structural overlap shows up in margin consistency and revenue growth trajectory.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
The price setup looks more supportive for United Therapeutics Corporation, but Novo Nordisk A/S still has the stronger structure.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
One company is still expanding while the other is contracting, which creates a very wide growth split.
Capital efficiency also runs the other way, with a 10.3-point ROIC edge acting as a real counterforce.
The lead is built on both growth and stability — though profitability still provides a counterweight.
Break down the NOVO-B.CO vs UTHR comparison across all dimensions with the full interactive tool.
Explore how NOVO-B.CO and UTHR each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.